Pantomed (Pantoprazole)

Pantomed (pantoprazole) is indicated for several acid‑related gastrointestinal conditions.

• Gastro‑oesophageal reflux disease (GERD): reduces gastric acid exposure, relieving heartburn and regurgitation.
• Erosive esophagitis: promotes healing of acid‑induced esophageal lesions.
• Peptic ulcer disease: facilitates ulcer closure by maintaining a higher gastric pH.
• Stress ulcer prophylaxis: prevents development of gastric ulcers in critically ill or postoperative patients.

• Pantoprazole is a benzimidazole‑derived proton pump inhibitor that binds covalently to the sulfhydryl group of the H+/K+‑ATPase enzyme located on gastric parietal cell membranes. By irreversibly inhibiting this proton pump, it blocks the final step of gastric acid secretion, leading to a sustained increase in gastric pH for up to 24 hours after a single dose. The inhibition is dose‑dependent and persists until new enzyme molecules are synthesized.

Pantomed may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: loose stools occurring during treatment.
• Nausea: transient feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.
• Injection site reactions: erythema or mild pain at the IV site.

Serious or Rare Side Effects

• Severe hypersensitivity: rash, pruritus, angioedema, or anaphylaxis.
• Clostridioides difficile infection: persistent diarrhea with possible colitis.
• Electrolyte disturbances: hypomagnesemia or hypocalcemia.
• Hepatic dysfunction: elevated transaminases or jaundice.
• Acute interstitial nephritis: renal impairment with fever and eosinophilia.

Before initiating Pantomed therapy, clinicians should consider several precautionary measures to ensure safe use.

• Assess renal function: dose adjustment may be required in severe impairment.
• Review concomitant medications: avoid co‑administration with drugs that require gastric acidity for absorption.
• Monitor for infection: prolonged acid suppression can increase risk of gastrointestinal infections.
• Evaluate liver status: use caution in patients with hepatic impairment.
• Pregnancy and lactation: limited data; prescribe only if benefit outweighs potential risk.
• Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Pantomed can interact with other medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid)

• Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption due to increased gastric pH.
• HIV protease inhibitors (e.g., atazanavir, nelfinavir): decreased plasma concentrations.
• Clopidogrel: reduced antiplatelet effect when combined with pantoprazole.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, monitor coagulation parameters.
• Methotrexate: higher serum levels may occur, especially in renal impairment.
• Digoxin: slight increase in serum concentration, monitor for toxicity.